Bessemer Group Inc Hutchmed (China) LTD Transaction History

Bessemer Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$8.59 - $20.77 $3.07 Million - $7.43 Million	-357,577 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$23.7 - $39.27 $10,688 - $17,710	-451 Reduced 0.13%	357,577 $14 Million
Q1 2021 May 13, 2021	BUY	$27.01 - $36.8 $2.23 Million - $3.04 Million	82,682 Added 30.03%	358,028 $10.1 Million
Q3 2020 Nov 12, 2020	BUY	$25.8 - $34.61 $7.1 Million - $9.53 Million	275,346 New	275,346 $8.89 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.01B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.